Pharmaforce ApS: Financial statements 2019
CVR: 26394198
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Pharmaforce ApS (CVR 26394198) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 2,813,985 and a net result of DKK 263,539 compared with DKK 1,177,199 the year before. That is a decrease of 23.6% compared with the year before. Equity in the 2019 report amounted to DKK 1,427,084. The solvency ratio was 32.8%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 2,813,985
- Profit/Loss
- DKK 263,539
- Equity
- DKK 1,427,084
- Total Assets
- DKK 4,357,012
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 2.8 mio. | 264 t. | 1.4 mio. | 4 |
| 2018 | - | 3.7 mio. | 1.2 mio. | 2.2 mio. | 3 |
| 2017 | - | 2.3 mio. | 826 t. | 986 t. | 2 |
| 2016 | - | 1.1 mio. | -74 t. | 161 t. | 2 |
| 2015 | - | 312 t. | 149 t. | 234 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Pharmaforce ApS has published its annual report for 2018. Gross profit came to DKK 3,684,787, and the net result was DKK 1,177,199.
About Pharmaforce ApS
Pharmaforce ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Mads Louie Frazier. The company is owned by Pfam Holding ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,238,511 and a net result of DKK 914,232 compared with DKK 1,494,355 the year before. Equity in the 2025 report amounted to DKK 4,328,882.